Document is current
Any future updates will be listed below
-
Authors
Weigl, Benedikt
Pistorius, Regina
Brumberg, Joachim
Pozzi, Nicoló G.
Buck, Andreas
Muthuraman, Muthuraman
Isaias, Ioannis U.
Volkmann, Jens
Joutsa, Juho
Reich, Martin M.
- License Information
-
More Information
Article History
Received: 23 November 2025
Accepted: 6 May 2026
First Online: 20 May 2026
Competing interests
: Author M.M. is Deputy Editor of npj Parkinson’s Disease. M.M. was not involved in the journal’s review of, or decisions related to, this manuscript. All further competing interests are unrelated to the submitted work. J.B. has received honoraria from Novartis. J.V. reports honoraria from Boston Scientific, Medtronic, Newronika, UCB, Zambon, and Abbott. J.J. has received consulting fees from Adamant Health, Summaryx, and Teva Finland; lecturer honoraria from Insightec, Novartis, Lundbeck, Addictum, Nordic Infucare; conference travel support from Insightec, AbbVie, Abbott; and owns stock of Neurologic Finland and Suomen Neurolaboratorio and acts as an advisory board member for Teva Finland. M.M.R. has received grant support and honoraria for speaking from Medtronic and Boston Scientific. The other authors declare that they have no competing interests.
